These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 2772012)

  • 1. [Preparation of oral sustained-action preparations with a base of biologically degradable polymers. 2. Preparation of matrix tablets with a base of polylactic acid].
    Mank R; Kala H; Richter M
    Pharmazie; 1989 May; 44(5):328-30. PubMed ID: 2772012
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Preparation of preoral sustained-release preparations with a base of biodegradable polymers. 3. Preparation of matrix tablets with a base of poly-3-hydroxybutyric acid].
    Mank R; Kala H; Richter M; Babel W; Sattler K
    Pharmazie; 1989 Aug; 44(8):545-7. PubMed ID: 2594825
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Preparation of peroral sustained release drug forms on a base of biodegradable polymers. 1. Preparation and characterization of polylactic acid].
    Mank R; Kala H; Richter M
    Pharmazie; 1989 Apr; 44(4):276-9. PubMed ID: 2772002
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Preparations of matrix tablets from a polyacrylate base].
    Mank R; Zessin G; Fahr F
    Pharmazie; 1986 Jan; 41(1):42-4. PubMed ID: 3960947
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Preparation of peroral delayed-action drug forms using biological polymers as the base. 4. Preparation of erosion tablets with a base of starch hydrolysis products].
    Mank R; Kala H; Lorenz A
    Pharmazie; 1989 Sep; 44(9):617-8. PubMed ID: 2608707
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Preparations of preoral sustained-release preparations with a biological polymer base. 5 (correct title supplied from Table of Contents)].
    Keipert S; Siebenbrodt I
    Pharmazie; 1990 Jul; 45(8):594-5. PubMed ID: 2080206
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of physicochemical properties of polylactic acid on the characteristics and in vitro release patterns of polylactic acid microspheres containing local anesthetics.
    Wakiyama N; Juni K; Nakano M
    Chem Pharm Bull (Tokyo); 1982 Jul; 30(7):2621-8. PubMed ID: 7139823
    [No Abstract]   [Full Text] [Related]  

  • 8. Preparation of polylactic acid microcapsules containing ciprofloxacin.
    Yu WP; Wong JP; Chang TM
    J Microencapsul; 1998; 15(4):515-23. PubMed ID: 9651872
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Compound erythromycin sustained release preparation and its in vitro release].
    Chen HX; Chen ZP; Wang QR; Liu ZK; Ma QL
    Yao Xue Xue Bao; 2011 Nov; 46(11):1385-9. PubMed ID: 22260035
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insights into the mechanisms of chitosan-anionic polymers-based matrix tablets for extended drug release.
    Li L; Wang L; Li J; Jiang S; Wang Y; Zhang X; Ding J; Yu T; Mao S
    Int J Pharm; 2014 Dec; 476(1-2):253-65. PubMed ID: 25290814
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biodegradable polylactic acid nanocapsules containing ciprofloxacin: preparation and characterization.
    Yu WP; Wong JP; Chang TM
    Artif Cells Blood Substit Immobil Biotechnol; 1999 May; 27(3):263-78. PubMed ID: 10226689
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The influence of polymer glass transition temperature and molecular weight on drug release from tablets containing poly(DL-lactic acid).
    Omelczuk MO; McGinity JW
    Pharm Res; 1992 Jan; 9(1):26-32. PubMed ID: 1589405
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug/polymer matrix swelling and dissolution.
    Harland RS; Gazzaniga A; Sangalli ME; Colombo P; Peppas NA
    Pharm Res; 1988 Aug; 5(8):488-94. PubMed ID: 3244656
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The influence of thermal treatment on the physical-mechanical and dissolution properties of tablets containing poly(DL-lactic acid).
    Omelczuk MO; McGinity JW
    Pharm Res; 1993 Apr; 10(4):542-8. PubMed ID: 8483836
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of polylactic acid for the preparation of microparticulate drug delivery systems.
    Conti B; Pavanetto F; Genta I
    J Microencapsul; 1992; 9(2):153-66. PubMed ID: 1593398
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preparation and evaluation in vitro of polylactic acid microspheres containing local anesthetics.
    Wakiyama N; Juni K; Nakano M
    Chem Pharm Bull (Tokyo); 1981 Nov; 29(11):3363-8. PubMed ID: 7337936
    [No Abstract]   [Full Text] [Related]  

  • 17. Controlled release of newer quinolones from biodegradable systems based on poly(lactic acid).
    Andreopoulos AG
    J Biomater Appl; 1995 Oct; 10(2):163-70. PubMed ID: 8618209
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Formulation and evaluation of matrix type mucoadhesive tablets aimed at treating oral aphtha.
    Ikeuchi-Takahashi Y; Watanabe N; Sasatsu M; Onishi H
    Drug Dev Ind Pharm; 2013 Aug; 39(8):1254-61. PubMed ID: 22934736
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Hydrophilic gel matrix tablets for oral administration of drugs].
    Rabisková M; Vostalová L; Medvecká G; Horácková D
    Ceska Slov Farm; 2003 Sep; 52(5):211-7. PubMed ID: 14619697
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oestrone loaded poly(l-lactic acid) microspheres: preparation, evaluation and in vitro release kinetics.
    Parikh BV; Upadrashta SM; Neau SH; Nuessle NO
    J Microencapsul; 1993; 10(2):141-53. PubMed ID: 8331489
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.